A.M. Mandard

7.2k total citations · 4 hit papers
49 papers, 5.6k citations indexed

About

A.M. Mandard is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, A.M. Mandard has authored 49 papers receiving a total of 5.6k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Pulmonary and Respiratory Medicine, 18 papers in Oncology and 12 papers in Surgery. Recurrent topics in A.M. Mandard's work include Esophageal Cancer Research and Treatment (11 papers), Sarcoma Diagnosis and Treatment (11 papers) and Vascular Tumors and Angiosarcomas (7 papers). A.M. Mandard is often cited by papers focused on Esophageal Cancer Research and Treatment (11 papers), Sarcoma Diagnosis and Treatment (11 papers) and Vascular Tumors and Angiosarcomas (7 papers). A.M. Mandard collaborates with scholars based in France, Netherlands and Luxembourg. A.M. Mandard's co-authors include P Ségol, M Gignoux, J. Marnay, M. Henry‐Amar, J.-C. Mandard, Alexandre Roussel, G Samama, Jean François Petiot, Sylvie Bonvalot and John Jacob and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Journal of Clinical Oncology.

In The Last Decade

A.M. Mandard

49 papers receiving 5.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Pathologic assessment of tumor regression after preoperative chemoradiotherapy of esophageal carcinoma. Clinicopathologic correlations

1994 1.6k citations A.M. Mandard, J.-C. Mandard et al. Cancer profile →
Chemoradiotherapy Followed by Surgery Compared with Surgery Alone in Squamous-Cell Cancer of the Esophagus

1997 1.0k citations Jean-François Bosset, M Gignoux et al. New England Journal of Medicine profile →
Comparative study of the National Cancer Institute and French Federation of Cancer Centers Sarcoma Group grading systems in a population of 410 adult patients with soft tissue sarcoma.

1997 640 citations J.M. Coindre, F. Bonichon et al. Journal of Clinical Oncology profile →
Prognostic factors in adult patients with locally controlled soft tissue sarcoma. A study of 546 patients from the French Federation of Cancer Centers Sarcoma Group.

1996 487 citations J.M. Coindre, Philippe Terrier et al. Journal of Clinical Oncology profile →

Peers

Countries citing papers authored by A.M. Mandard

Since Specialization

Citations

This map shows the geographic impact of A.M. Mandard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A.M. Mandard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A.M. Mandard more than expected).

Fields of papers citing papers by A.M. Mandard

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A.M. Mandard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A.M. Mandard. The network helps show where A.M. Mandard may publish in the future.

Co-authorship network of co-authors of A.M. Mandard

This figure shows the co-authorship network connecting the top 25 collaborators of A.M. Mandard. A scholar is included among the top collaborators of A.M. Mandard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A.M. Mandard. A.M. Mandard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Lymphocyte-rich classical Hodgkin lymphoma (LRCHL): clinico-pathological characteristics and outcome of a rare entity 2005 ·Annals of Oncology ·Daphne de Jong, J. Bosq, KA MacLennan, J Diébold, Josée Audouin, Jacques Chasle, A.M. Mandard, J. Marnay, M. Henry‐Amar	18
2	Genetic steps in the development of squamous cell carcinoma of the esophagus 2000 ·Mutation Research/Reviews in Mutation Research ·A.M. Mandard, Pierre Hainaut, Monica Hollstein	178
3	The utility of mitotic index, oestrogen receptor and Ki-67 measurements in the creation of novel prognostic indices fornode-negative breast cancer 1999 ·European Journal of Surgical Oncology ·P C Clahsen, C.J.H. Van de Velde, Christian Duval, C. Pallud, A.M. Mandard, A Delobelle-Deroïde, Lambertus van den Broek, Marc J. van de Vijver	78
4	Image analysis software for automatic DNA ploidy assessment of archival solid tumours 1999 ·Cytometry ·D. Bloyet, Paulette Herlin, Eric Masson, Benoît Plancoulaine, (unknown), (unknown), (unknown), (unknown), A.M. Mandard, (unknown), (unknown), (unknown)	1
5	p53 protein accumulation and response to adjuvant chemotherapy in premenopausal women with node-negative early breast cancer. 1998 ·Journal of Clinical Oncology ·P C Clahsen, C J van de Velde, Christian Duval, C. Pallud, A.M. Mandard, A Delobelle-Deroïde, Lambertus van den Broek, Tarek Sahmoud, Marc J. van de Vijver	144
6	Expression of p53 in oesophageal squamous epithelium from surgical specimens resected for squamous cell carcinoma of the oesophagus, with special reference to uninvolved mucosa 1997 ·The Journal of Pathology ·A.M. Mandard, J. Marnay, (unknown), Sandrine Bénard, J.-C. Mandard	14
7	Chemoradiotherapy Followed by Surgery Compared with Surgery Alone in Squamous-Cell Cancer of the Esophagus breakdown → 1997 ·New England Journal of Medicine ·Jean-François Bosset, M Gignoux, Jean–Pierre Triboulet, Emmanuel Tiret, Georges Mantion, Dominique Élias, P Lozac’h, Jean-Claude Ollier, (unknown), Mariette Mercier, Tarek Sahmoud, P Ségol, (unknown), Jean‐Pierre Arnaud, (unknown), A.M. Mandard, (unknown)	1025
8	Prognostic factors for patients with localized primary malignant fibrous histiocytoma: A multicenter study of 216 patients with multivariate analysis 1996 ·Cancer ·V Le Doussal, Jean‐Michel Coindre, Agnès Leroux, K. Hacène, Philippe Terrier, Nguyen Binh Bui, F. Bonichon, Françoise Collin, A.M. Mandard, G Contesso	134
9	Thin melanomas with unusual aggressive behavior: A report of nine cases 1996 ·Journal of the American Academy of Dermatology ·C Vilmer, Christiane Bailly, V Le Doussal, S. Lasry, (unknown), M. Delaunay, A.M. Mandard	29
10	Expression of Bcl-2 in node-negative breast cancer is associated with various prognostic factors, but does not predict response to one course of perioperative chemotherapy 1996 ·British Journal of Cancer ·(unknown), P C Clahsen, Jan Hein van Dierendonck, Christian Duval, C. Pallud, A.M. Mandard, A Delobelle-Deroïde, C J van de Velde, Marc J. van de Vijver	104
11	Prognostic factors in adult patients with locally controlled soft tissue sarcoma. A study of 546 patients from the French Federation of Cancer Centers Sarcoma Group. breakdown → 1996 ·Journal of Clinical Oncology ·J.M. Coindre, Philippe Terrier, N.B. Bui, F. Bonichon, F. Collin, V Le Doussal, A.M. Mandard, M O Vilain, J Jacquemier, H Duplay, Xavier Sastre, Claude Barlier, M. Henry‐Amar, Josette Macé-Lesec’h, G Contesso	487
12	Pathologic assessment of tumor regression after preoperative chemoradiotherapy of esophageal carcinoma. Clinicopathologic correlations breakdown → 1994 ·Cancer ·A.M. Mandard, (unknown), J.-C. Mandard, J. Marnay, M. Henry‐Amar, Jean François Petiot, Alexandre Roussel, John Jacob, P Ségol, G Samama, (unknown), Sylvie Bonvalot, M Gignoux	1594
13	Prevalence survey of precancerous lesions of the oesophagus in a high-risk population for oesophageal cancer in France 1993 ·European Journal of Cancer Prevention ·J H Jacob, Aart Brutel de la Rivière, A.M. Mandard, Nicolás Muñoz, M. Crespi, Y Etienne, Xavier Castellsagué, (unknown), (unknown), (unknown)	11
14	Development of an automatic program for the stereological estimation of the volume weighted mean volume of cell nuclei 1992 ·Pathology - Research and Practice ·Eric Masson, Paulette Herlin, D. Bloyet, (unknown), A.M. Mandard	5
15	Three‐dimensional DNA image cytometry by confocal scanning laser microscopy in thick tissue blocks 1991 ·Cytometry ·(unknown), Jany Vassy, Paulette Herlin, (unknown), Eric Masson, (unknown), (unknown), Santos Carvajal‐Gonzalez, Angela M. Downs, A.M. Mandard	47
16	Prognostic factors in soft tissue sarcomas. A multivariate analysis of 109 cases 1989 ·Cancer ·A.M. Mandard, (unknown), J. Marnay, J.-C. Mandard, Jacques Chasle, (unknown), (unknown), Paulette Herlin, (unknown), A Tanguy, (unknown), J.S. Abbatucci	133
17	Silver Impregnation of Membranes on Undeplasticized Semi-Thin Sections for Morphometry 1989 ·Pathology - Research and Practice ·Paulette Herlin, A.M. Mandard, Benoît Plancoulaine, (unknown), (unknown), D. Bloyet	1
18	Amplification of epidermal growth factor receptor gene but no evidence of ras mutations in primary human esophageal cancers. 1988 ·PubMed ·Monica Hollstein, Alida M.M. Smits, (unknown), Hironori Yamasaki, Johannes L. Bos, A.M. Mandard, Christian Partensky, Ruggero Montesano	115
19	Radiotherapy as an integrated part of the treatment of soft tissue sarcomas 1984 ·Radiotherapy and Oncology ·J.S. Abbatucci, (unknown), (unknown), A.M. Mandard, A Tanguy, A Busson	23
20	Sarcomes des tissus mous: progrès thérapeutiques par l'application d'un protocole pluridisciplinaire. 1981 ·Bulletin du Cancer ·J.S. Abbatucci, (unknown), A.M. Mandard, (unknown), A Tanguy, (unknown)	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact